Coming October 2: SITC releases abstract titles with each presenting author’s institution (nearly 1,300 last year). We’ll add them to this guide once they’re out.

Spatial biology, models and technology at SITC 2026

Nov 4–8, 2026 Phoenix, AZ ~6k attendees Website

64 organizations at SITC 2026 present work in spatial biology, models & technology: 52 suppliers and service providers, 7 universities and research institutes, 4 cancer centres and hospitals and 1 government or non-profit body. Between them they bring 23 presentations to the program. Most represented: U.S. Food and Drug Administration (8 on the program), Dana-Farber Cancer Institute (6 on the program), MD Anderson Cancer Center (5 on the program). 61 of them have their own page in this guide. As of Sep 29, 2026.

All 242 organizations at SITC 2026 →

Showing 1–9 of 64 organizations

Organization	SITC 2026 Attendance
U.S. Food and Drug Administration Silver Spring, MD
fda.gov Government & non-profit U.S. federal agency that regulates drugs, biologics and medical devices, including cancer immunotherapies.	Session Wed Nov 4 2:10pm–2:55pm Panel Discussion 1: Conversations with FDA Oncology Leaders on Hot Topics Encanto AB Regulatory Session Wed Nov 4 3:10pm–3:55pm Panel Discussion 2: Biomarker Discovery and Digital AI Encanto AB Biomarkers · AI & data Session Wed Nov 4 4:10pm–4:55pm Panel Discussion 3: Regulatory Framework for New IO Agents Encanto AB Regulatory · New agents Talk Fri Nov 6 2:45pm–3:00pm Part of Session 106b: Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip From Conventional to New Approach Methodologies: Regulatory Considerations for Immuno-Oncology Safety Assessment 301A Regulatory · Models & tech
Dana-Farber Cancer Institute Boston, MA
dana-farber.org Cancer centres & hospitals Harvard-affiliated cancer treatment and research center in Boston.	Workshop Thu Nov 5 5:00pm–9:00pm Launching Biotech Startups: Funding, Pitching, Partnerships 5:00pm–5:45pmWelcome Reception 5:55pm–6:55pmHigh-Impact Talks from Pharma Leaders 6:55pm–7:15pmPanel 7:00pm–7:50pmFinancing and Partnership Panel 8:00pm–9:00pmClosing Networking Reception Plenary Fri Nov 6 8:40am–9:10am Part of Session 102: Richard V. Smalley Memorial Award and Lectureship Getting Off the Rollercoaster: Personalized Cancer Vaccines Come of Age Halls BC Vaccines Plenary Fri Nov 6 11:10am–11:30am Part of Session 103: Thomas Waldmann Memorial Plenary Session: Cancer Vaccines, Current and Future The Cancer Dark Proteome: A Rich Source of Tumor-Selective Cryptic Antigens Halls BC Vaccines Session Fri Nov 6 9:40am–11:30am Thomas Waldmann Memorial Plenary Session: Cancer Vaccines, Current and Future Halls BC Vaccines 9:44am–10:04amDiscovery and Development of a Pancreatic Cancer RNA VaccineMemorial Sloan Kettering Cancer Center 10:04am–10:24amUpdates on Clinical Results from the AMPLIFY-7P Study of a Lymph Node-Targeted Kras VaccineScripps Research 10:24am–10:37amAbstract presentation — title not yet released 10:37am–10:57amLearning from Checkpoint Blockade: Prioritizing Neoantigens and Shared Tumor Antigens for Cancer VaccinesUniversity of Toulouse 10:57am–11:10amAbstract presentation — title not yet released 11:10am–11:30amThe Cancer Dark Proteome: A Rich Source of Tumor-Selective Cryptic AntigensDana-Farber Cancer Institute Talk Fri Nov 6 2:10pm–2:30pm Part of Session 106a: Combination Therapies Involving Cell Therapy CAR-Enhancers: Programmable Boosters for Durable Cell Therapy Halls BC Cell therapy Talk Fri Nov 6 2:30pm–2:45pm Part of Session 106b: Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip Dynamic Immune Profiling Using Human Ex Vivo Tumor Models 301A Models & tech Session Sat Nov 7 5:20pm–6:40pm Oral Abstract Session 4 301D 5:20pm–6:35pm5 abstract presentations — titles not yet released
MD Anderson Cancer Center Houston, TX
mdanderson.org Cancer centres & hospitals University of Texas comprehensive cancer center in Houston focused on cancer patient care, research and education.	Session Thu Nov 5 12:00pm–1:30pm Career Paths for Physician Scientists Encanto AB Workshop Thu Nov 5 7:00pm–8:00pm Early Career Scientist Speed Mentoring 7:00pm–8:00pmSpeed Mentoring - Group Mentoring 7:00pm–7:30pmSpeed Mentoring - One-on-One 7:30pm–8:00pmSpeed Mentoring - One-on-One 2 Talk Sat Nov 7 10:00am–10:20am Part of Session 202: Spatial Biology Spatial Biomarkers of Immunotherapy Response Halls BC Biomarkers · Models & tech Talk Sat Nov 7 3:55pm–4:15pm Part of Session 206b: IO in Low Mutation Burden Cancers From the Clinic to the Lab: Investigating Mechanisms of Response and Resistance to Immune Checkpoint Therapy Hall A Tumor biology Session Sat Nov 7 3:30pm–4:50pm Oral Abstract Session 3 301D 3:30pm–4:45pm5 abstract presentations — titles not yet released Talk Sun Nov 8 11:30am–11:45am Part of Session 303: COOPERATIVE BINDING: The bi-specific VEGF/PD(L)-1 Inhibitor Approach to cancer immunotherapy: Savior or Pretender? Biology and Clinical Results of Anti-VEGF+PD1 Bispecfics Hall A New agents
University of Pittsburgh Pittsburgh, PA
pitt.edu Universities & research institutes Public research university in Pittsburgh, Pennsylvania.	Session Thu Nov 5 12:00pm–1:30pm Navigating Academia as Junior Faculty (as MD or PhD) Encanto AB Talk Thu Nov 5 3:15pm–3:25pm Part of Session I – Grant Writing Essentials Funding Your Research Through Industry Collaboration Encanto AB Workshop Thu Nov 5 2:30pm–5:05pm Grant Writing Workshop 2:30pm–4:30pmSession I – Grant Writing Essentials 4:05pm–4:30pmThe Importance of the Patient Advocate Perspective in Research and How to Effectively Connect with Advocates 4:30pm–5:00pmSession II – Breakout Sessions 5:00pm–5:05pmClosing Talk Thu Nov 5 4:30pm–5:00pm Part of Session II – Breakout Sessions Breakout Table: Interfacing with Industry (Biotech Grants) Encanto AB Talk Thu Nov 5 4:30pm–5:00pm Part of Session II – Breakout Sessions Breakout Table: Low-preliminary Data Grants (DP5, R21, High Risk/High Reward Grants) Encanto AB Talk Fri Nov 6 1:50pm–2:10pm Part of Session 106d: Mechanisms of irAEs Diet and Microbiome Drivers of Immune Related Adverse Events Hall A Clinical · Tumor biology Session Sat Nov 7 9:35am–11:15am Spatial Biology Halls BC Models & tech 9:40am–10:00amHigh-plex Imaging and Spatial TranscriptomicsUniversity of Queensland 10:00am–10:20amSpatial Biomarkers of Immunotherapy ResponseMD Anderson Cancer Center 10:20am–10:40amComputational Spatial Biology and AI-assisted InterpretationProvidence Genomics 10:40am–11:10am2 abstract presentations — titles not yet released Session Sat Nov 7 11:15am–12:15pm Hot Topic Symposium: External Factors Contributing to Immunotherapy Response Halls BC Tumor biology 11:15am–11:30amPostprandial Metabolism and its Potential to Enhance Immunotherapy ResponsesUniversity of Pittsburgh 11:30am–11:45amThe Role of the Intestinal Microbiome in Cancer ImmunotherapyCity of Hope 11:45am–12:05pmDebate: Pros and Cons on Time of Day and Checkpoint InhibitorsEmory University School of Medicine, Fred Hutchinson Cancer Center Talk Sat Nov 7 11:15am–11:30am Part of Session 203: Hot Topic Symposium: External Factors Contributing to Immunotherapy Response Postprandial Metabolism and its Potential to Enhance Immunotherapy Responses Halls BC Tumor biology Talk Sat Nov 7 4:25pm–4:35pm Part of Session 206c: Microbiome and Metabolism Gut Microbiome Function Shapes the Efficacy of Tumor Infiltrating Lymphocyte (TIL) Therapy in Melanoma 301A Tumor biology · Cell therapy Session Sat Nov 7 3:30pm–4:50pm Microbiome and Metabolism 301A Tumor biology 3:30pm–3:45pmCorrecting the Gut Microbiome Dysbiosis in OncologyCentre hospitalier de l'Université de Montréal (CHUM) 3:45pm–4:00pmToward Metabotherapy for CancerStanford University 4:00pm–4:15pmIntratumoral Bacterial Elements in Brain TumorsMoffitt Cancer Center 4:15pm–4:25pmGut Microbiota Metabolite Control of Antitumor CD8 T Cell TraffickingMassachusetts General Hospital 4:25pm–4:35pmGut Microbiome Function Shapes the Efficacy of Tumor Infiltrating Lymphocyte (TIL) Therapy in MelanomaUniversity of Pittsburgh Plenary Sun Nov 8 9:20am–9:30am Part of Session 301: Presidential Session Expert Disucussant Hall A
University of Pennsylvania Philadelphia, PA
upenn.edu Universities & research institutes Private research university in Philadelphia whose Perelman School of Medicine is active in cell therapy research.	Workshop Thu Nov 5 12:00pm–1:30pm Early Career Scientist Meet-the-Expert Lunch 12:00pm–1:30pmBioinformatics, Big Data, and AI (Table 1) 12:00pm–1:30pmBioinformatics, Big Data, and AI (Table 2) 12:00pm–1:30pmCareer Paths for Physician Scientists 12:00pm–1:30pmCareers Outside Academia and Industry – Careers in Policy, Advocacy and Non-Profit Organizations 12:00pm–1:30pmCollaborating with Industry 12:00pm–1:30pmCollaborating with Industry on Investigator-initiated Clinical Trials 12:00pm–1:30pmHow to Navigate the Graduate Student to Postdoc Transition 12:00pm–1:30pmHow to Navigate the Postdoc to PI Transition 12:00pm–1:30pmIndustry: Building Your Career in Industry (Big Pharma) 12:00pm–1:30pmIndustry: Building Your Career in Industry (Startup and Midsize Pharma) 12:00pm–1:30pmLeadership Opportunities in Immuno-oncology (Academics and Industry) 12:00pm–1:30pmNavigating Academia as Junior Faculty (as MD or PhD) 12:00pm–1:30pmNon-science Skills Needed to be a Successful Postdoc or PI 12:00pm–1:30pmSetting Up a Successful Biotech (Midsize Pharma and Small Startups) 12:00pm–1:30pmTranslational Research: Human Samples to Lab and Back to the Clinic 12:00pm–1:30pmTranslational Research: Mice to Humans 12:00pm–1:30pmTransitioning from Academia to Industry 12:00pm–1:30pmCareers in Venture Capital and Biotechnology Investing Session Thu Nov 5 12:00pm–1:30pm Translational Research: Mice to Humans Encanto AB Models & tech Talk Thu Nov 5 3:05pm–3:15pm Part of Session I – Grant Writing Essentials K or F Awards? Finding Your NIH Career Development Awards Encanto AB Talk Fri Nov 6 4:30pm–4:45pm Part of Session 107d: Cytokine Engineering and Clinical Translation mRNA Based Delivery of Cytokines 301BC New agents
Netherlands Cancer Institute Amsterdam, Netherlands
nki.nl Cancer centres & hospitals Comprehensive cancer centre combining a research institute and the Antoni van Leeuwenhoek hospital.	Talk Fri Nov 6 2:15pm–2:30pm Part of Session 106b: Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip Personalizing Cancer Immunotherapy Using Patient-Derived Tumor Models 301A Models & tech Plenary Sat Nov 7 8:30am–9:00am Part of Session 201: Keynote Address T Cell Recognition of Human Cancer: 'Cracking the Code’ Halls BC Tumor biology
Case Western Reserve University Cleveland, OH
case.edu Universities & research institutes Private research university in Cleveland with a school of medicine.	Session Thu Nov 5 12:00pm–1:30pm Bioinformatics, Big Data, and AI (Table 1) Encanto AB AI & data Session Fri Nov 6 1:45pm–3:25pm Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip 301A Models & tech 2:00pm–2:15pmPatient-Derived Brain Tumor Organoids to Model and Overcome Myeloid ImmunosuppressionCase Western Reserve University 2:15pm–2:30pmPersonalizing Cancer Immunotherapy Using Patient-Derived Tumor ModelsNetherlands Cancer Institute 2:30pm–2:45pmDynamic Immune Profiling Using Human Ex Vivo Tumor ModelsDana-Farber Cancer Institute 2:45pm–3:00pmFrom Conventional to New Approach Methodologies: Regulatory Considerations for Immuno-Oncology Safety AssessmentU.S. Food and Drug Administration 3:00pm–3:20pm2 abstract presentations — titles not yet released Talk Fri Nov 6 2:00pm–2:15pm Part of Session 106b: Human Ex Vivo Models for Immunotherapy Testing: From Tumor Explants to Tumor-on-Chip Patient-Derived Brain Tumor Organoids to Model and Overcome Myeloid Immunosuppression 301A Models & tech · Tumor biology
Koch Institute for Integrative Cancer Research at MIT Cambridge, MA
ki.mit.edu Universities & research institutes MIT cancer research centre bringing biologists and engineers together.	Session Thu Nov 5 12:00pm–1:30pm Translational Research: Mice to Humans Encanto AB Models & tech Session Fri Nov 6 3:55pm–5:30pm Cytokine Engineering and Clinical Translation 301BC New agents 4:00pm–4:15pmAnchored Cytokine Therapy for Cancer: Engineering the Next Generation of IOMass Eye and Ear 4:15pm–4:30pmAnchored and Targeted CytokinesNew York University 4:30pm–4:45pmmRNA Based Delivery of CytokinesUniversity of Pennsylvania 4:45pm–5:25pm4 abstract presentations — titles not yet released
Weizmann Institute of Science Rehovot, Israel
weizmann.ac.il Universities & research institutes Multidisciplinary research institute and graduate school in Rehovot, Israel.	Session Sat Nov 7 9:35am–11:15am Spatial Biology Halls BC Models & tech 9:40am–10:00amHigh-plex Imaging and Spatial TranscriptomicsUniversity of Queensland 10:00am–10:20amSpatial Biomarkers of Immunotherapy ResponseMD Anderson Cancer Center 10:20am–10:40amComputational Spatial Biology and AI-assisted InterpretationProvidence Genomics 10:40am–11:10am2 abstract presentations — titles not yet released Talk Sat Nov 7 3:30pm–3:50pm Part of Session 206a: New Avenues in Myeloid Cells Leveraging Single-Cell Technologies to Engineer the Immune System Halls BC Models & tech